Samsung Biologics, a leading contract development and manufacturing organization (CDMO), announced the completion of its acquisition of a manufacturing facility in Rockville, Maryland from GSK, establishing the company's first manufacturing presence in the United States. Samsung Biologics will continue supplying the …
Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Transcend Therapeutics, Inc. (Transcend) announce that the two companies entered into an agreement , under which Otsuka, through its wholly owned subsidiary Otsuka America, Inc., will fully acquire Transcend. The acquisition is expected to be completed in the second quarter…
Insilico Medicine ("Insilico", 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, and Tenacia Biotechnology (Hong Kong) Co., Limited ("Tenacia"), a commercial-stage biopharmaceutical company dedicated to developing innovative therapeutics for patients with underserved neur…
Infosys, a global leader in next-generation digital services and consulting, announced a definitive agreement to acquire Optimum Healthcare IT, recognized as a Best in KLAS healthcare digital transformation and consulting firm recognized for helping provider organizations drive large-scale transformation. The acquisi…
Insilico Medicine, a clinical-stage drug discovery and development company driven by generative artificial intelligence (AI), today announced a strategic research collaboration with ASKA Pharmaceutical Co., Ltd., a specialized pharmaceutical company with a strong focus on internal medicine, obstetrics, and gynecology.…
Abbott announced it has completed the acquisition of Exact Sciences, establishing Abbott as a leader in fast-growing cancer screening and diagnostics segments and enabling the company to serve millions of additional people. "Abbott's global scale, track record of operational and commercial excellence and work with he…
Earendil Labs, an AI-driven biotechnology company advancing next-generation biologics, announced that it has raised $787 million in financing rounds. The investment included participation by a group of leading global investors, including Dimension Capital, DST Global, INCE Capital, Luminous Ventures, Miracle Capital, …
Celltrion announced that it has signed a contract manufacturing (CMO) agreement with a global pharmaceutical company for the supply of drug substance. The counterparty remains undisclosed to ensure business confidentiality. Under the agreement, Celltrion will supply drug substance for three years from 2027 through 20…
Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company and global leader in blood management solutions, has entered into a collaboration with Taiwan Bio Therapeutics Inc. (Taiwan Bio) to transition regulatory T-cell (Treg) manufacturing onto the automated Quantum Flex platform, supporting a move…
Agilent Technologies Inc. announced it has entered into a definitive agreement to acquire Biocare Medical, a global leader in clinical pathology, from an investor group led by Excellere Partners and GHO Capital Partners LLP, in an all-cash transaction valued at $950 million. “The acquisition of Biocare enhances Agil…
Page 15 of 39